Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142483 |
| CAS No | NA |
| Mol.F. | C21H14N4O3S |
| Mol.Wt. | 402.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142484 |
| CAS No | NA |
| Mol.F. | C21H15N5O2S |
| Mol.Wt. | 401.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142485 |
| CAS No | NA |
| Mol.F. | C22H17N5O4S |
| Mol.Wt. | 447.47 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142486 |
| CAS No | NA |
| Mol.F. | C44H35N9O3S2 |
| Mol.Wt. | 801.94 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142487 |
| CAS No | NA |
| Mol.F. | C44H34N10O4S2 |
| Mol.Wt. | 830.94 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142488 |
| CAS No | NA |
| Mol.F. | C7H3I2N3O |
| Mol.Wt. | 398.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142489 |
| CAS No | NA |
| Mol.F. | C15H12N4O2S |
| Mol.Wt. | 312.35 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142490 |
| CAS No | NA |
| Mol.F. | C15H12N4O3S |
| Mol.Wt. | 328.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142491 |
| CAS No | NA |
| Mol.F. | C22H19N5O2S |
| Mol.Wt. | 417.49 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142492 |
| CAS No | NA |
| Mol.F. | C44H33N11O5S2 |
| Mol.Wt. | 859.94 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142493 |
| CAS No | NA |
| Mol.F. | C22H17N5O5S |
| Mol.Wt. | 463.47 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142494 |
| CAS No | NA |
| Mol.F. | C30H22N8O4S2 |
| Mol.Wt. | 622.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142495 |
| CAS No | NA |
| Mol.F. | C7H4N4O3 |
| Mol.Wt. | 192.13 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142496 |
| CAS No | 1038-06-8 |
| Mol.F. | C18H20N2O2 |
| Mol.Wt. | 296.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142497 |
| CAS No | NA |
| Mol.F. | C19H19N3O |
| Mol.Wt. | 305.38g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142498 |
| CAS No | NA |
| Mol.F. | C9H6N8O3S |
| Mol.Wt. | 306.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |